Shandong Xinhua Pharmaceutical Company Limited (SHNXY)
- Previous Close
0.00 - Open
18.19 - Bid --
- Ask --
- Day's Range
18.19 - 18.19 - 52 Week Range
18.19 - 18.19 - Volume
100 - Avg. Volume
0 - Market Cap (intraday)
2B - Beta (5Y Monthly) -0.03
- PE Ratio (TTM)
22.74 - EPS (TTM)
0.80 - Earnings Date Oct 25, 2024 - Oct 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 5, 2024
- 1y Target Est
--
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
www.xhzy.com7,064
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SHNXY
View MorePerformance Overview: SHNXY
Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHNXY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHNXY
View MoreValuation Measures
Market Cap
1.21B
Enterprise Value
1.27B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
6.03%
Return on Assets (ttm)
3.52%
Return on Equity (ttm)
10.57%
Revenue (ttm)
8.16B
Net Income Avi to Common (ttm)
492.11M
Diluted EPS (ttm)
0.80
Balance Sheet and Cash Flow
Total Cash (mrq)
996.33M
Total Debt/Equity (mrq)
28.19%
Levered Free Cash Flow (ttm)
326.98M